SPECTRA XT - "The Extended Platform" "Revital Treatment" - 1064 nm quasi-long pulse Ultimate skin rejuvenation solution to revitalize your skin If you are one of those people who have suffered from such problems as non-responsive large pores and wrinkles, then Revital Treatment is the no-downtime skin rejuvenation solution you can rely on. * Lunch-time procedure * Absolutely no downtime "Onychomycosis Treatment"-1064 nm quasi-long pulse New approach to treat nail fungus Spectra XT’s powerful energy output delivery further supports or replaces current conventional treatments which use systemic drugs and topical creams. It is a safer treatment especially for those who can’t take systemic drugs due to liver or kidney dysfunction. * Perfect replacement treatment for those who can’t take drugs * Provides synergic effect with current treatments Courtesy of B. Rümmelein, MD, Switzerland Lutronic Corporation Lutronic China Yuzhou plaza 2001 room, Jingang road 299 no, Pudong district, Shanghai 200120, China TEL: +86-21-5019-3891,3893 / FAX: +86-21-5019-3865 Lutronic Center, 219 Sowon-ro, Deogyang-gu, Goyang-si, Gyeonggi-do, KOREA TEL. +82 31 908 3440 / FAX. +82 1600 3660 e-mail. [email protected] 1 North Avenue, Unit C, Burlington, MA 01803, USA TEL. +1 888 588 7644 Lutronic Germany 12F, Tokyo Front Terrace, 2-3-14, Higashi-Shinagawa, Shinagawa-ku, Tokyo, JAPAN TEL: +81-3-6433-3041/ FAX: +81-3-6433-3042 E-MAIL: [email protected] lutronic.com ©2018, LUTRONIC Group of Companies. All rights reserved. LUTRONIC, its logo, SPECTRA XT are trademarks or registered trademarks of the LUTRONIC Group of Companies. This product or the use of this product is covered by one or more US and foreign patents or patent applications pending. SPECTRA XT-BR-20180202 *Specifications are subject to change without notice. For International Use

"The Extended Platform" - Pigmented Lesions, Acne, Erythema, Melasma, Tattoo, Skin Rejuvenation, Wrinkles, Pores, Onychomycosis and even more "Gold Toning" - 595 nm IT IS NOT JUST A QSNY, BUT “THE EXTENDED PLATFORM” Science and medicine are constantly on the move and the wise manufacturer moves with them, so there is a constant drive to develop novel systems even though existing systems are working well. On the other hand, it is logistically impossible for a manufacturer to try to keep launching completely novel devices without a great deal of system testing and clinical trials. Rather than struggling...